NexImmune (7370) Financial Statements
NexImmune Financial Overview
NexImmune's market cap is currently $124. The company's EPS TTM is $-18.58; its P/E ratio is 0.00; NexImmune has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Mar 21 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.02M | $ -1.50M | $ -870.28K | $ -618.99K | $ -436.37K |
| Operating Income | $ -29.19M | $ -63.08M | $ -53.26M | $ -27.85M | $ -20.89M |
| EBITDA | $ -28.17M | $ -61.51M | $ -49.13M | $ -27.56M | $ -20.45M |
| Net Income | $ -32.34M | $ 514.18M | $ -51.75M | $ -31.64M | $ -20.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.65M | $ 34.64M | $ 81.82M | $ 5.10M | $ 10.14M |
| Total Assets | $ 8.59M | $ 43.06M | $ 91.03M | $ 11.30M | $ 13.72M |
| Total Debt | $ 68.81K | $ 1.02M | $ 0.00 | $ 19.12M | $ 0.00 |
| Net Debt | $ -3.13M | $ -33.62M | $ -30.33M | $ 14.09M | $ -9.13M |
| Total Liabilities | $ 5.08M | $ 10.76M | $ 7.27M | $ 27.06M | $ 3.11M |
| Stockholders' Equity | $ 3.51M | $ 32.30M | $ 83.76M | $ -15.75M | $ 10.61M |
| Cash Flow | |||||
| Free Cash Flow | $ -31.48M | $ -52.45M | $ -48.14M | $ -27.27M | $ -20.66M |
| Operating Cash Flow | $ -31.43M | $ -51.19M | $ -45.79M | $ -26.40M | $ -19.42M |
| Investing Cash Flow | $ -44.49K | $ 50.32M | $ -53.81M | $ 221.94K | $ 9.42M |
| Financing Cash Flow | $ 0.00 | $ 5.18M | $ 124.89M | $ 22.08M | $ 18.76M |
Currency in USD
